Fluvoxamine is a potent inhibitor of tacrine metabolism

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 1999年 / 767卷 / 1期
关键词：
Public Health; Plasma Concentration; Single Dose; Treatment Regimen; Clinical Pharmacology;
D O I：
10.2165/00128415-199907670-00004
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [1] Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo
    Larsen J.T.
    Hansen L.L.
    Spigset O.
    Brøsen K.
    European Journal of Clinical Pharmacology, 1999, 55 (5) : 375 - 382
  • [2] Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo
    Larsen, JT
    Hansen, LL
    Spigset, O
    Brosen, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (05) : 375 - 382
  • [3] Fluvoxamine is a potent inhibitor of the metabolism of caffeine in vitro
    Rasmussen, BB
    Nielsen, TL
    Brosen, K
    PHARMACOLOGY & TOXICOLOGY, 1998, 83 (06): : 240 - 245
  • [4] Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro
    Wang, JS
    Backman, JT
    Wen, X
    Taavitsainen, P
    Neuvonen, PJ
    Kivistö, KT
    PHARMACOLOGY & TOXICOLOGY, 1999, 85 (05): : 201 - 205
  • [5] Influence of fluvoxamine on tacrine metabolism in vitro: Potential implication for the hepatotoxicity in vivo
    Becquemont, L
    LeBot, MA
    Riche, C
    Beaune, P
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1996, 10 (02) : 156 - 157
  • [6] Influence of the CYP1A2 inhibitor fluvoxamine on tacrine pharmacokinetics in humans
    Becquemont, L
    Ragueneau, I
    LeBot, MA
    Riche, C
    FunckBrentano, C
    Jaillon, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (06) : 619 - 627
  • [7] FLUVOXAMINE IS A POTENT INHIBITOR OF CYTOCHROME-P4501A2
    BROSEN, K
    SKJELBO, E
    RASMUSSEN, BB
    POULSEN, HE
    LOFT, S
    BIOCHEMICAL PHARMACOLOGY, 1993, 45 (06) : 1211 - 1214
  • [8] Tacrine-fluvoxamine interaction study in healthy volunteers
    Larsen, JT
    Hansen, LL
    Brosen, K
    NORDIC JOURNAL OF PSYCHIATRY, 1998, 52 (02) : 122 - 122
  • [9] ENOXACIN - A POTENT INHIBITOR OF THEOPHYLLINE METABOLISM
    BECKMANN, J
    ELSASSER, W
    GUNDERTREMY, U
    HERTRAMPF, R
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 33 (03) : 227 - 230
  • [10] Bis(7)-tacrine, a novel dimeric AChE inhibitor, is a potent GABAA receptor antagonist
    Li, CY
    Wang, H
    Xue, H
    Carlier, PR
    Hui, KM
    Pang, YP
    Li, ZW
    Han, YF
    NEUROREPORT, 1999, 10 (04) : 795 - 800
12345